A multicenter, randomized, double-blind, placebo-controlled trial of thalidomide plus dexamethasone versus dexamethasone alone as initial therapy for newly diagnosed multiple myeloma.

被引：0
|
作者：
Rajkumar, S. V.
Hussein, M.
Catalano, J.
Jedrzejcak, W.
Sirkovich, S.
Olesnyckyj, M.
Yu, Z.
Knight, R.
Zeldis, J. B.
Blade, J.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Frankston Hosp, Frankston, Australia
[4] Med Acad Warsaw, Warsaw, Poland
[5] UAMS, Kiev Inst Oncol, Kiev, Ukraine
[6] Celgene Corp, Summit, NJ USA
[7] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：426S / 426S
页数：1
相关论文
共 50 条
  • [21] Dexamethasone versus ondansetron in combination with dexamethasone for the prophylaxis of postoperative vomiting in pediatric outpatients: a double-blind, randomized, placebo-controlled clinical trial
    de Orange, Flavia A.
    Marques, Jaime
    Flores, Marilia
    Borges, Paulo S. G. N.
    PEDIATRIC ANESTHESIA, 2012, 22 (09) : 890 - 896
  • [22] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF THE EFFECTS OF DEXAMETHASONE ON POSTOPERATIVE SWELLING
    EDILBY, GI
    CANNIFF, JP
    HARRIS, M
    JOURNAL OF DENTAL RESEARCH, 1982, 61 (04) : 556 - 556
  • [23] Neurocysticercosis in children: clinical therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases
    Gogia, S
    Talukdar, B
    Choudhury, V
    Arora, BS
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (04) : 416 - 421
  • [24] Cyclophosphamide, thalidomide and dexamethasone (CTD) as initial therapy for newly diagnosed multiple myeloma patients.
    Chavez, Jule Franve Vasquez
    Mendoza, Rossana Esther Ruiz
    Llerena, Karina Mayra Aliaga
    Valencia, Fernando
    Enriquez, Daniel
    Palacios, Victor
    Casanova, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Thalidomide plus dexamethasone (Thal/Dex) and thalidomide alone (Thal) as first line therapy for newly diagnosed myeloma (MM).
    Rajkumar, SV
    Hayman, S
    Fonseca, R
    Dispenzieri, A
    Lacy, MQ
    Geyer, S
    Wellik, L
    Lust, JA
    Kyle, RA
    Greipp, PR
    Gertz, MA
    Witzig, TE
    BLOOD, 2000, 96 (11) : 168A - 168A
  • [26] Phase III trial of thalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 452 - 453
  • [27] Dexamethasone for the prevention of postextubation airway obstruction: A prospective, randomized, double-blind, placebo-controlled trial
    Anene, O
    Meert, KL
    Uy, H
    Simpson, P
    Sarnaik, AP
    CRITICAL CARE MEDICINE, 1996, 24 (10) : 1666 - 1669
  • [28] Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: A clinical trial coordinated by the eastern cooperative oncology group
    Rajkumar, SV
    Blood, E
    Vesole, D
    Fonseca, R
    Greipp, PR
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) : 431 - 436
  • [29] CONTROLLING DELAYED VOMITING - DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING PLACEBO, DEXAMETHASONE ALONE, AND METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING CISPLATIN
    KRIS, MG
    GRALLA, RJ
    TYSON, LB
    CLARK, RA
    CIRRINCIONE, C
    GROSHEN, S
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 108 - 114
  • [30] Dexamethasone Therapy for Septic Arthritis in Children Results of a Randomized Double-blind Placebo-controlled Study
    Harel, Liora
    Prais, Dario
    Bar-On, Elhanan
    Livni, Gilat
    Hoffer, Vered
    Uziel, Yosef
    Amir, Jacob
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2011, 31 (02) : 211 - 215
12345